Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia
Clinical trial NCT05192941 · COMPLETED
Trial details
- NCT number
- NCT05192941
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-08
- Primary completion
- 2024-06-11
- Enrollment
- 1770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.